These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in colon carcinoma cells. Her NG; Kesari S; Nurmemmedov E Cell Cycle; 2020 Jul; 19(13):1590-1601. PubMed ID: 32423265 [TBL] [Abstract][Full Text] [Related]
5. Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors. Bastola P; Bilkis R; De Souza C; Minn K; Chien J Sci Rep; 2019 Jul; 9(1):11002. PubMed ID: 31358864 [TBL] [Abstract][Full Text] [Related]
6. A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6. Leinonen H; Cheng C; Pitkänen M; Sander CL; Zhang J; Saeid S; Turunen T; Shmara A; Weiss L; Ta L; Ton T; Koskelainen A; Vargas JD; Kimonis V; Palczewski K J Pharmacol Exp Ther; 2021 Jul; 378(1):31-41. PubMed ID: 33931547 [TBL] [Abstract][Full Text] [Related]
7. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer. Costantini S; Capone F; Polo A; Bagnara P; Budillon A Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340 [TBL] [Abstract][Full Text] [Related]
8. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells. Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933 [TBL] [Abstract][Full Text] [Related]
9. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy. Lan B; Chai S; Wang P; Wang K Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of the ATPase p97/VCP: From basic research to clinical applications. Kilgas S; Ramadan K Cell Chem Biol; 2023 Jan; 30(1):3-21. PubMed ID: 36640759 [TBL] [Abstract][Full Text] [Related]
11. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. Kobayashi T; Tanaka K; Inoue K; Kakizuka A J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637 [TBL] [Abstract][Full Text] [Related]
12. VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy. Cheng C; Weiss L; Leinonen H; Shmara A; Yin HZ; Ton T; Do A; Lee J; Ta L; Mohanty E; Vargas J; Weiss J; Palczewski K; Kimonis V J Transl Med; 2022 Jan; 20(1):21. PubMed ID: 34998409 [TBL] [Abstract][Full Text] [Related]
13. Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia. Gugliotta G; Sudo M; Cao Q; Lin DC; Sun H; Takao S; Le Moigne R; Rolfe M; Gery S; Müschen M; Cavo M; Koeffler HP Neoplasia; 2017 Oct; 19(10):750-761. PubMed ID: 28843399 [TBL] [Abstract][Full Text] [Related]
14. Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells. Vekaria PH; Kumar A; Subramaniam D; Dunavin N; Vallurupalli A; Schoenen F; Ganguly S; Anant S; McGuirk JP; Jensen RA; Rao R Leukemia; 2019 Jul; 33(7):1675-1686. PubMed ID: 30664664 [TBL] [Abstract][Full Text] [Related]
16. Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083. Tang WK; Odzorig T; Jin W; Xia D Mol Pharmacol; 2019 Mar; 95(3):286-293. PubMed ID: 30591537 [TBL] [Abstract][Full Text] [Related]
17. Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis. Anderson DJ; Le Moigne R; Djakovic S; Kumar B; Rice J; Wong S; Wang J; Yao B; Valle E; Kiss von Soly S; Madriaga A; Soriano F; Menon MK; Wu ZY; Kampmann M; Chen Y; Weissman JS; Aftab BT; Yakes FM; Shawver L; Zhou HJ; Wustrow D; Rolfe M Cancer Cell; 2015 Nov; 28(5):653-665. PubMed ID: 26555175 [TBL] [Abstract][Full Text] [Related]
18. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein. He J; Zhu Q; Wani G; Wani AA Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256 [TBL] [Abstract][Full Text] [Related]
19. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598 [TBL] [Abstract][Full Text] [Related]
20. Spironolactone-induced XPB degradation requires TFIIH integrity and ubiquitin-selective segregase VCP/p97. Chauhan AK; Li P; Sun Y; Wani G; Zhu Q; Wani AA Cell Cycle; 2021 Jan; 20(1):81-95. PubMed ID: 33381997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]